GB919118947A
GB9118947D0
(en)
|
1991-09-05 |
1991-09-05 |
Method for the optical resolution of racemic 6-(4-amino-phenyl)-methyl-pyridazin-3(2h)one and preparation of optically active derivatives thereof
|
GB9127145A
GB2251615B
(en)
|
1991-01-03 |
1991-12-20 |
(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
|
YU200391A
YU48767B
(en)
|
1991-01-03 |
1991-12-27 |
(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl) phenyl]hydrazono] propanedinitrile, process for the preparation and intermediates
|
SI9112003A
SI9112003A
(en)
|
1991-01-03 |
1991-12-27 |
(-)-//4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl) phenyl/hydrazono/propanedinitrile
|
IL11402891A
IL114028A
(en)
|
1991-01-03 |
1991-12-30 |
Process for the optical resolution of (+-)-6-(4-aminophenyl)-5-methyl pyridazin 3(2H) one and intermediates thereof
|
IL10055391A
IL100553A
(en)
|
1991-01-03 |
1991-12-30 |
(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)-phenyl]hydrazono]propanedinitrile pharmaceutically acceptable salts thereof and pharmaceutical compositions containing them
|
AU11535/92A
AU645399B2
(en)
|
1991-01-03 |
1992-01-03 |
(-)-((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl) phenyl)-hydrazono)propanedinitrile
|
RU93052411A
RU2118317C1
(en)
|
1991-01-03 |
1992-01-03 |
(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phen- -yl]hydrozono]propanedinitrile and its pharmaceutically acceptable salts, pharmaceutical composition based on thereof, method of synthesis of intermediate compound and method of synthesis of end compound
|
DE69201640T
DE69201640T2
(en)
|
1991-01-03 |
1992-01-03 |
(-) - [[4- (1,4,5,6-TETRAHYDRO-4-METHYL-6-OXO-3-PYRIDAZINYL) PHENYL] -HYDRAZONO] PROPANDINITRILE.
|
CA002099262A
CA2099262C
(en)
|
1991-01-03 |
1992-01-03 |
(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl) phenyl]hydrazono]propanedinitrile
|
DK92901317.5T
DK0565546T3
(en)
|
1991-01-03 |
1992-01-03 |
(-) - ((4- (1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl) phenyl) hydrazono) propanedinitrile
|
ES92901317T
ES2070627T3
(en)
|
1991-01-03 |
1992-01-03 |
PROCESS TO PREPARE (-) - ((4- (1,4,5,6-TETRAHIDRO-4-METHYL-6-OXO-3-PIRIDACINIL) FENIL) -HIDRAZONE) PROPANODINITRILO.
|
RO93-00896A
RO111847B1
(en)
|
1991-01-03 |
1992-01-03 |
Optical izomer for the //4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)-phenyl/hydr azono/propane dinitrile, preparation process thereof and intermediaries for the process making thereof
|
KR1019930701800A
KR100207145B1
(en)
|
1991-01-03 |
1992-01-03 |
(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl) phenyl]-hydrazono] propanedinitrile
|
EP92901317A
EP0565546B1
(en)
|
1991-01-03 |
1992-01-03 |
(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile
|
AT92901317T
ATE119525T1
(en)
|
1991-01-03 |
1992-01-03 |
(-)-((4-(1,4,5,6-TETRAHYDRO-4-METHYL-6-OXO-3-PYRIDAZINYL)PHENYL>-HYDRAZONO>PROPANENITRILE.
|
HU9301911A
HU218659B
(en)
|
1991-01-03 |
1992-01-03 |
Process for producing (-) ((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridinazinyl)-phenyl)-hydrazyno)-propane-dinitryl and pharmaceutical compositions containing it
|
GEAP19922483A
GEP19991868B
(en)
|
1991-01-03 |
1992-01-03 |
(-)-[[4-(1,4,5,6-Tetrahydro-4-Methyl-6- oxo-3-Pyridazinyl)Phenyl]-Hydrazono¬]Propane¬di¬nit¬rile
|
JP4501428A
JP2635445B2
(en)
|
1991-01-03 |
1992-01-03 |
(-)-[[4- (1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl) phenyl] hydrazono] propanedinitrile
|
CA002314115A
CA2314115C
(en)
|
1991-01-03 |
1992-01-03 |
Process for the optical resolution of the racemic 6-(4-amino-phenyl)-5- methyl-pyridazin-3(2h)one
|
PCT/FI1992/000003
WO1992012135A1
(en)
|
1991-01-03 |
1992-01-03 |
(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile
|
US08/081,360
US5424428A
(en)
|
1991-01-03 |
1992-01-03 |
(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]pr
|
NZ241194A
NZ241194A
(en)
|
1991-01-03 |
1992-01-06 |
The pure (-) enantiomer of ((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrozono)propanedinitrile, compositions and new intermediates
|
HR921251A
HRP921251B1
(en)
|
1991-01-03 |
1992-11-12 |
(-)-//4-(1,4,5,6-tetrahydro-4-methlyl-6-oxo-3-pyridazinyl) yl/hydrazono/propanedinitrile
|
FI932618A
FI105183B
(en)
|
1991-01-03 |
1993-06-09 |
Process for the preparation of (-) - [[4- (1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl) phenyl] hydrazono] propanedinitrile useful in the treatment of heart failure
|
PL92310250A
PL169415B1
(en)
|
1991-01-03 |
1993-06-25 |
Method of obtaining essentially optically pure (-)- or (+)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazone]propanodinitrile
|
PL92299920A
PL169435B1
(en)
|
1991-01-03 |
1993-06-25 |
Method of obtaining pure 6-(4-aminophenyl)-5-methyl pyridazin-3(2h)-one
|
IE920002A
IE72101B1
(en)
|
1991-01-03 |
1993-06-25 |
(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile
|
NO932367A
NO300682B1
(en)
|
1991-01-03 |
1993-06-28 |
(-) - ££ 4- (1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl) phenyl | hydrazono | propanedinitrile
|
BG97915A
BG62002B1
(en)
|
1991-01-03 |
1993-06-29 |
(-)-//4-(1,4,5,6-terrahydro-4-methyl-6-oxo-pyridazinile)phenyl/-hy drazone/propandinitryl
|
EE9400252A
EE02946B1
(en)
|
1991-01-03 |
1994-11-17 |
(-) - [[4- (1,4,5,6-Tetrahydro-4-methyl-6-oxo-3-pyridazinyl) phenyl] -hydrazono] propanedinitrile, process for its preparation, salts, compositions, intermediates and uses
|
US08/455,035
US5512571A
(en)
|
1991-01-03 |
1995-05-31 |
(-) 4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl!-hydra-zono!propanedinitrile
|
US08/454,856
US5569657A
(en)
|
1991-01-03 |
1995-05-31 |
(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile
|
HK117395A
HK117395A
(en)
|
1991-01-03 |
1995-07-20 |
(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]propanedinitrile
|
LVP-95-358A
LV11174B
(en)
|
1991-01-03 |
1995-11-30 |
(-)-££4- (1,4,5,6- tetrahydro- 4- methyl- 6- oxo- 3- pyridazinyl ) phenyl-|- hydrazono| propanedinitrile
|
CY187896A
CY1878A
(en)
|
1991-01-03 |
1996-04-05 |
(-)-((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)-hydrazono)propanedinitrile
|
JP8308528A
JP3015748B2
(en)
|
1991-01-03 |
1996-11-19 |
(±) -6- (4-aminophenyl) -5-methylpyridazin-3 (2H) one optical separation method and intermediate in the method
|
BR1100737A
BR1100737A
(en)
|
1991-01-03 |
1997-05-09 |
Compound; pharmaceutical composition; process for the optical resolution of (+ -) - 6- (4-aminophenyl) -5methyl pyridazin-3 (2h) one; process for the preparation of (nil) phenyl / hydrazone / propane dinitrile 08 (+) - [[4-yl / propane dinitrile; and diastereomeric intermediate salts
|
FI972077A
FI109902B
(en)
|
1991-01-03 |
1997-05-15 |
New cardiotonic agent, hypotensive and vasodilator - is optically pure (-)enantiomer of ((4-(1,4,5,6-tetra:hydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)propane:di:nitrile
|
NO2001021C
NO2001021I1
(en)
|
1991-01-03 |
2001-11-20 |
Levosimendan
|
LU90920C
LU90920I2
(en)
|
1991-01-03 |
2002-05-17 |
Levosimendan (simday)
|